The role of patient-physician trust in moderating medication nonadherence due to cost pressures.

BACKGROUND Prescription drug costs constitute a burden for many chronically ill adults and are strongly related to patients' likelihood of using less medication than prescribed. We examined the extent to which patients' trust in their physicians may moderate the impact of economic constraints and other risk factors for cost-related adherence problems. METHODS A total of 912 patients with diabetes recruited from 5 Veterans Affairs health systems completed a detailed cross-sectional survey. Patients reported their level of physician trust using a standard scale and were stratified into high-trust (n = 557) and low-trust (n = 355) groups. We fit multivariate logistic regression models with terms characterizing the interactions between physician trust and (1) patients' out-of-pocket medication costs and (2) patients' income, as well as other possible risk factors for cost-related underuse. RESULTS Patients with higher out-of-pocket costs were more likely to forgo medications because of cost pressures when physician trust levels were low. Having a low income was only associated with cost-related adherence problems in the context of low physician trust. Patients who reported medication underuse for reasons other than cost were 4 times as likely as other patients to also report cost-related underuse, and those with significant depressive symptoms had more than twice the risk of cost-related underuse compared with those without depression (both P<.05). CONCLUSIONS These findings suggest that a trusting physician relationship may moderate the impact of cost pressures on patients' medication adherence. More generally, addressing noncost barriers to adherence may reduce rates of cost-related medication underuse.

[1]  John D. Piette,et al.  Dimensions of patient-provider communication and diabetes self-care in an ethnically diverse population , 2003, Journal of General Internal Medicine.

[2]  K. Covinsky,et al.  Self-restriction of medications due to cost in seniors without prescription coverage , 2001, Journal of General Internal Medicine.

[3]  MS Dr. G. Caleb Alexander MD,et al.  Barriers to patient-physician communication about out-of-pocket costs , 2007, Journal of General Internal Medicine.

[4]  J. Piette,et al.  Problems due to medication costs among VA and non-VA patients with chronic illnesses. , 2004, The American journal of managed care.

[5]  T. Wagner,et al.  Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk. , 2004, American journal of public health.

[6]  E. Keeler,et al.  Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage. , 2004, JAMA.

[7]  Carol M Mangione,et al.  Diabetes Care Quality in the Veterans Affairs Health Care System and Commercial Managed Care: The TRIAD Study , 2004, Annals of Internal Medicine.

[8]  K. Langa,et al.  The Health Effects of Restricting Prescription Medication Use Because of Cost , 2004, Medical care.

[9]  M. Solomon,et al.  Benefits and the Use of Drugs by the Chronically Ill , 2004 .

[10]  D. Bates,et al.  Patient characteristics and experiences associated with trust in specialist physicians. , 2004, Archives of internal medicine.

[11]  T. Wagner,et al.  Health Insurance Status, Cost-Related Medication Underuse, and Outcomes Among Diabetes Patients in Three Systems of Care , 2004, Medical care.

[12]  C. Richardson,et al.  Addressing the needs of patients with multiple chronic illnesses: the case of diabetes and depression. , 2004, The American journal of managed care.

[13]  Lynn Ordway,et al.  Antecedents of adherence to medical recommendations: Results from the medical outcomes study , 1992, Journal of Behavioral Medicine.

[14]  R. Epstein,et al.  The effect of incentive-based formularies on prescription-drug utilization and spending. , 2003, The New England journal of medicine.

[15]  John J. Chen.  Communicating complex information: the interpretation of statistical interaction in multiple logistic regression analysis. , 2003, American journal of public health.

[16]  Irl B Hirsch,et al.  The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. , 2003, General hospital psychiatry.

[17]  R Brian Haynes,et al.  Helping patients follow prescribed treatment: clinical applications. , 2002, JAMA.

[18]  F. Camacho,et al.  Measuring Patients’ Trust in their Primary Care Providers , 2002, Medical care research and review : MCRR.

[19]  I. Wilson,et al.  Prescription drug coverage and seniors: how well are states closing the gap? , 2002, Health affairs.

[20]  Aneil Mishra,et al.  Trust in physicians and medical institutions: what is it, can it be measured, and does it matter? , 2001, The Milbank quarterly.

[21]  S. Goold,et al.  Trust and the ethics of health care institutions. , 2001, The Hastings Center report.

[22]  F. Mostashari,et al.  Trust and the Acceptance of and Adherence to Antiretroviral Therapy , 2001, Journal of acquired immune deficiency syndromes.

[23]  D. Thom,et al.  Training physicians to increase patient trust. , 2001, Journal of evaluation in clinical practice.

[24]  W. Katon,et al.  Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. , 2000, Archives of internal medicine.

[25]  B. Svarstad,et al.  Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment. , 2000, Patient education and counseling.

[26]  M. Irwin,et al.  Screening for depression in the older adult: criterion validity of the 10-item Center for Epidemiological Studies Depression Scale (CES-D) , 1999, Archives of internal medicine.

[27]  A. Stewart,et al.  Further validation and reliability testing of the Trust in Physician Scale. The Stanford Trust Study Physicians. , 1999, Medical care.

[28]  A. Ryan.  Medication compliance and older people: a review of the literature. , 1999, International journal of nursing studies.

[29]  M. Stewart,et al.  Evidence on patient-doctor communication. , 1999, Cancer prevention & control : CPC = Prevention & controle en cancerologie : PCC.

[30]  D. Mechanic,et al.  Public trust and initiatives for new health care partnerships. , 1998, The Milbank quarterly.

[31]  J E Ware,et al.  The Primary Care Assessment Survey: tests of data quality and measurement performance. , 1998, Medical care.

[32]  P D Cleary,et al.  Patients' trust in their physicians: effects of choice, continuity, and payment method. , 1998, Journal of general internal medicine.

[33]  F Davidoff,et al.  Important Elements of Outpatient Care: A Comparison of Patients' and Physicians' Opinions , 1996, Annals of Internal Medicine.

[34]  B. Martin,et al.  The impact of implementing a more restrictive prescription limit on Medicaid recipients. Effects on cost, therapy, and out-of-pocket expenditures. , 1996, Medical care.

[35]  D. Mechanic,et al.  Changing medical organization and the erosion of trust. , 1996, The Milbank quarterly.

[36]  DiMatteo Mr.  Patient adherence to pharmacotherapy: the importance of effective communication. , 1995 .

[37]  J. de Haes,et al.  Doctor-patient communication: a review of the literature. , 1995, Social science & medicine.

[38]  M. Dimatteo.  Patient adherence to pharmacotherapy: the importance of effective communication. , 1995, Formulary.

[39]  D L Patrick,et al.  Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). , 1994, American journal of preventive medicine.

[40]  W H Rogers,et al.  Physicians' characteristics influence patients' adherence to medical treatment: results from the Medical Outcomes Study. , 1993, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[41]  L. Ried,et al.  The Effect of Drug Co-Payments on Utilization and Cost of Pharmaceuticals in a Health Maintenance Organization , 1990, Medical care.

[42]  Stephen B. Soumerai,et al.  Payment Restrictions for Prescription Drugs under Medicaid , 1987 .

[43]  S B Soumerai,et al.  Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity. , 1987, The New England journal of medicine.

[44]  R P Caterinicchio,et al.  Testing plausible path models of interpersonal trust in patient-physician treatment relationships. , 1979, Social science & medicine. Medical psychology & medical sociology.